Delcath Systems DCTH Stock
Delcath Systems Price Chart
Delcath Systems DCTH Financial and Trading Overview
| Delcath Systems stock price | 12.29 USD |
| Previous Close | 11.69 USD |
| Open | 11.7 USD |
| Bid | 8.32 USD x 200 |
| Ask | 14.79 USD x 200 |
| Day's Range | 11.42 - 11.8 USD |
| 52 Week Range | 8.12 - 14.18 USD |
| Volume | 383.33K USD |
| Avg. Volume | 427.06K USD |
| Market Cap | 397.34M USD |
| Beta (5Y Monthly) | 0.519 |
| PE Ratio (TTM) | 1151 |
| EPS (TTM) | 0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 21.35 USD |
DCTH Valuation Measures
| Enterprise Value | 308.95M USD |
| Trailing P/E | 1151 |
| Forward P/E | -22.568628 |
| PEG Ratio (5 yr expected) | 1.6 |
| Price/Sales (ttm) | 4.393408 |
| Price/Book (mrq) | 3.5198777 |
| Enterprise Value/Revenue | 3.416 |
| Enterprise Value/EBITDA | -233.701 |
Trading Information
Delcath Systems Stock Price History
| Beta (5Y Monthly) | 0.519 |
| 52-Week Change | -17.015% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 14.18 USD |
| 52 Week Low | 8.12 USD |
| 50-Day Moving Average | 11.04 USD |
| 200-Day Moving Average | 10.25 USD |
DCTH Share Statistics
| Avg. Volume (3 month) | 427.06K USD |
| Avg. Daily Volume (10-Days) | 652.65K USD |
| Shares Outstanding | 34.52M |
| Float | 28.6M |
| Short Ratio | 6.54 |
| % Held by Insiders | 8.12% |
| % Held by Institutions | 48.92% |
| Shares Short | 3.11M |
| Short % of Float | 9.81% |
| Short % of Shares Outstanding | 9.01% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:700 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0.61% |
| Operating Margin (ttm) | -6.55% |
| Gross Margin | 85.97% |
| EBITDA Margin | -1.46% |
Management Effectiveness
| Return on Assets (ttm) | -0.95% |
| Return on Equity (ttm) | 0.58% |
Income Statement
| Revenue (ttm) | 90.44M USD |
| Revenue Per Share (ttm) | 2.5 USD |
| Quarterly Revenue Growth (yoy) | 26.30% |
| Gross Profit (ttm) | 77.75M USD |
| EBITDA | -1322000 USD |
| Net Income Avi to Common (ttm) | 561K USD |
| Diluted EPS (ttm) | 0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 89.3M USD |
| Total Cash Per Share (mrq) | 2.59 USD |
| Total Debt (mrq) | 907K USD |
| Total Debt/Equity (mrq) | 0.81 USD |
| Current Ratio (mrq) | 11.242 |
| Book Value Per Share (mrq) | 3.27 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 21.17M USD |
| Levered Free Cash Flow (ttm) | 19.65M USD |
Profile of Delcath Systems
| Country | United States |
| State | NY |
| City | Queensbury |
| Address | 566 Queensbury Avenue |
| ZIP | 12804 |
| Phone | 212 489 2100 |
| Website | https://www.delcath.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 156 |
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. The company also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. The company was founded in 1988 and is headquartered in Queensbury, New York.
Q&A For Delcath Systems Stock
What is a current DCTH stock price?
Delcath Systems DCTH stock price today per share is 12.29 USD.
How to purchase Delcath Systems stock?
You can buy DCTH shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Delcath Systems?
The stock symbol or ticker of Delcath Systems is DCTH.
Which industry does the Delcath Systems company belong to?
The Delcath Systems industry is Medical Devices.
How many shares does Delcath Systems have in circulation?
The max supply of Delcath Systems shares is 34.52M.
What is Delcath Systems Price to Earnings Ratio (PE Ratio)?
Delcath Systems PE Ratio is 1229.00000000 now.
What was Delcath Systems earnings per share over the trailing 12 months (TTM)?
Delcath Systems EPS is 0.01 USD over the trailing 12 months.
Which sector does the Delcath Systems company belong to?
The Delcath Systems sector is Healthcare.
Delcath Systems DCTH included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25587.04 USD — |
-2.21
|
13.85B USD — | 25513.26 USD — | 25882.57 USD — | — - | 13.85B USD — |
|
US Tech Composite Total Return
XCMP
US
|
31560.2 USD — |
-2.21
|
— — | 31469.2 USD — | 31924.72 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1184.66 USD — |
+0.75
|
— — | 1174.72 USD — | 1192.68 USD — | — - | — — |
- {{ link.label }} {{link}}